Integra LifeSciences Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Integra LifeSciences (IART) Tops Q3 EPS by 3c, Updates FY Guidance
October 24, 2019 6:15 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.68, $0.03 better than the analyst estimate of $0.65. Revenue for the quarter came in at $379.1 million versus the consensus estimate of $376.69 million.
GUIDANCE:
Integra LifeSciences sees FY2019 EPS of $2.70-$2.75, versus the consensus of $2.73.... More
